Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Hereditary Neuropathy Foundation and Rarebase partner to find treatments for Charcot-Marie Tooth

Oct. 13, 2021

Regeneration of GABAergic neurons by in vivo reprogramming of glial cells reduces epileptic seizures

Oct. 13, 2021

New NLRP3 inflammasome inhibitors identified at Astellas Pharma

Oct. 13, 2021

New GABA(A) receptor agonists described by Sumitomo Dainippon Pharma

Oct. 11, 2021

Rare APOE variant gives insight into Alzheimer's pathogenesis

Oct. 8, 2021

Stealth's SBT-272 shows promise in murine model of ALS

Oct. 8, 2021

HC-070 attenuates stress-related excessive sensitivity to aversion and apathy for reward in mice

Oct. 8, 2021

AstraZeneca patents SLC12A5 activators

Oct. 8, 2021

Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases

Oct. 7, 2021

Thymosin beta4 reverses cognitive impairment in mouse model of AD

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...